Mingfang Xu

902 total citations
39 papers, 427 citations indexed

About

Mingfang Xu is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Mingfang Xu has authored 39 papers receiving a total of 427 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 16 papers in Oncology and 14 papers in Molecular Biology. Recurrent topics in Mingfang Xu's work include Lung Cancer Research Studies (8 papers), Lung Cancer Treatments and Mutations (6 papers) and Esophageal Cancer Research and Treatment (5 papers). Mingfang Xu is often cited by papers focused on Lung Cancer Research Studies (8 papers), Lung Cancer Treatments and Mutations (6 papers) and Esophageal Cancer Research and Treatment (5 papers). Mingfang Xu collaborates with scholars based in China, United States and Pakistan. Mingfang Xu's co-authors include Xueqin Yang, Xuemei Li, Na Peng, Dong Wang, Qiyu Sun, Li Cheng, Shuang Cao, Yanli Xiong, Yang Han and Haixia Wu and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Mingfang Xu

34 papers receiving 422 citations

Peers

Countries citing papers authored by Mingfang Xu

Since Specialization

Citations

This map shows the geographic impact of Mingfang Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingfang Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingfang Xu more than expected).

Fields of papers citing papers by Mingfang Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingfang Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingfang Xu. The network helps show where Mingfang Xu may publish in the future.

Co-authorship network of co-authors of Mingfang Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Mingfang Xu. A scholar is included among the top collaborators of Mingfang Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingfang Xu. Mingfang Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	Ore genesis of the Erdaodianzi gold deposit in Jilin Province, Northeast China: Constraints from Re–Os isotopes and geochemistry of pyrite	Ore Geology Reviews	Chan Li, Qun Yang et al.	0
2	Effects of anlotinib combined with camrelizumab and chemotherapy as first-line treatment for advanced esophageal squamous cell carcinoma on tumor immune microenvironment	Journal of Gastrointestinal Oncology	Mingfang Xu, Xiaodong Zhao et al.	0
3	Anlotinib plus camrelizumab and chemotherapy as first-line treatment in patients with advanced esophageal squamous cell carcinoma	Scientific Reports	Mingfang Xu, Yuzhu Jiang et al.	0
4	ESR1-dependent suppression of LCN2 transcription reverses autophagy-linked ferroptosis and enhances sorafenib sensitivity in hepatocellular carcinoma	Journal of Physiology and Biochemistry	Mingfang Xu, Zhiyong Zhu et al.	1
5	807MO High efficacy and safety of interleukin-6-knockdown CD19-targeted CAR-T cells in relapsed/refractory B-ALL patients	Annals of Oncology	Lianbo Yu, Lijuan Kang et al.	1
6	Impact of APOBEC3s on the occurrence, development and prognosis of esophageal squamous cell carcinoma	Future Oncology	He Xiao, Xiaoyan Dai et al.	1
7	Nuclear NME1 enhances the malignant behavior of A549 cells and impacts lung adenocarcinoma patient prognosis	iScience	Mingfang Xu, Xiaodong Zhao et al.	0
8	Differences in genetic diversity of <i>Pleuronichthys cornutus</i> in the coastal water of China and Japan based on three mitochondrial markers	Biodiversity Science	Mingfang Xu, Qun Zhang et al.	1
9	Estimating the prognosis of esophageal squamous cell carcinoma based on The Cancer Genome Atlas (TCGA) of m6A methylation-associated genes	Journal of Gastrointestinal Oncology	Xueqin Yang, Yi Yang et al.	12
10	Comparative analyses on epidemiological characteristics of dengue fever in Guangdong and Yunnan, China, 2004–2018	BMC Public Health	Yujuan Yue, Qiyong Liu et al.	17
11	Serum carcinoembryonic antigen elevation in benign lung diseases	Scientific Reports	Yi Yang, Mingfang Xu et al.	25
12	Clinicopathological characteristics and survival in lung signet ring cell carcinoma: a population-based study	Bosnian Journal of Basic Medical Sciences	Yan Xie, Yanli Xiong et al.	8
13	Characteristics and prognosis of telangiectatic osteosarcoma: a population-based study using the Surveillance, Epidemiology and End Results (SEER) database	Annals of Translational Medicine	Mingfang Xu, Nan Dai et al.	4
14	Complete response of radioresistant brain metastases from non-small cell lung cancer with temozolomide	Medicine	Yi Yang, Nan Dai et al.	5
15	Clinical characteristics and risk of second primary lung cancer after cervical cancer: A population-based study	PLoS ONE	Chengyuan Qian, Hong Liu et al.	7
16	Suppression of oncogenic protein translation via targeting eukaryotic translation initiation factor 4E overcomes chemo-resistance in nasopharyngeal carcinoma	Biochemical and Biophysical Research Communications	Mingfang Xu, Zezhang Tao et al.	6
17	Comparison of first-line chemotherapy based on irinotecan or other drugs to treat non-small cell lung cancer in stage IIIB/IV: a systematic review and meta-analysis	BMC Cancer	Xueqin Yang, Mingfang Xu et al.	17
18	Stereotactic body radiotherapy with concurrent chemotherapy extends survival of patients with limited stage small cell lung cancer: a single-center prospective phase II study	Medical Oncology	Yanli Xiong, Zejun Zhou et al.	16
19	Combined chemotherapy plus endostar with sequential stereotactic radiotherapy as salvage treatment for recurrent esophageal cancer with severe dyspnea: A case report and review of the literature	Oncology Letters	Mingfang Xu, Huan Huang et al.	16
20	Epidemiological studies on Echinochasmus liliputanus infection. I. Parasite infection and distribution in final hosts		Da‐Bing Lu, Jie Gao et al.	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact